172 related articles for article (PubMed ID: 1352902)
1. Symptomatology and electrodermal activity as predictors of neuroleptic response in young male schizophrenic inpatients.
Lindström EM; Ohlund LS; Lindström LH; Ohman A
Psychiatry Res; 1992 May; 42(2):145-58. PubMed ID: 1352902
[TBL] [Abstract][Full Text] [Related]
2. The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
Green MF; Nuechterlein KH; Satz P
Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035
[TBL] [Abstract][Full Text] [Related]
3. Type I and type II schizophrenia: relations between tonic electrodermal activity and clinical ratings before and after haloperidol treatment.
Maina G; Barzega G; Bellino S; Bogetto F; Ravizza L
Psychiatry Res; 1995 Jun; 57(1):49-56. PubMed ID: 7568558
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia.
Green MF; Nuechterlein KH
Psychiatry Res; 1988 Apr; 24(1):79-86. PubMed ID: 2899332
[TBL] [Abstract][Full Text] [Related]
5. Electrodermal and vascular orienting response in schizophrenic patients: relationship to symptoms and medication.
Schlenker R; Cohen R; Hubmann W; Mohr F; Wahlheim C; Watzl H; Werther P
Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):152-8. PubMed ID: 7669822
[TBL] [Abstract][Full Text] [Related]
6. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine.
Zahn TP; Pickar D
Biol Psychiatry; 1993 Jul 1-15; 34(1-2):3-12. PubMed ID: 8104043
[TBL] [Abstract][Full Text] [Related]
7. Relationships between electrodermal activity and symptomatology in schizophrenia.
Fuentes I; García Merita M; Miquel M; Rojo J
Psychopathology; 1993; 26(1):47-52. PubMed ID: 8511230
[TBL] [Abstract][Full Text] [Related]
8. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses.
Vaitl D; Lipp O; Bauer U; Schüler G; Stark R; Zimmermann M; Kirsch P
Schizophr Res; 2002 May; 55(1-2):147-58. PubMed ID: 11955974
[TBL] [Abstract][Full Text] [Related]
9. [Electrodermal reactivity in schizophrenic women with so-called basic symptoms].
Wolfersdorf M; Straub R; Barg T; Studemund H; Ruppe A
Fortschr Neurol Psychiatr; 1995 Sep; 63(9):363-7. PubMed ID: 7590561
[TBL] [Abstract][Full Text] [Related]
10. Electrodermal activity and therapeutic response to neuroleptic treatment in chronic schizophrenic in-patients.
Schneider SJ
Psychol Med; 1982 Aug; 12(3):607-13. PubMed ID: 7134318
[TBL] [Abstract][Full Text] [Related]
11. Skin conductance responding in schizophrenic patients with abnormal involuntary movements.
Mintz M; Alfisi S; Sigal M
Psychiatry Res; 1990 Oct; 34(1):19-27. PubMed ID: 1980017
[TBL] [Abstract][Full Text] [Related]
12. Electrodermal activity as a prodromal sign in schizophrenia.
Hazlett H; Dawson ME; Schell AM; Nuechterlein KH
Biol Psychiatry; 1997 Jan; 41(1):111-3. PubMed ID: 8988801
[No Abstract] [Full Text] [Related]
13. Concurrent and predictive electrodermal correlates of symptomatology in recent-onset schizophrenic patients.
Dawson ME; Nuechterlein KH; Schell AM; Mintz J
J Abnorm Psychol; 1992 Feb; 101(1):153-64. PubMed ID: 1537961
[TBL] [Abstract][Full Text] [Related]
14. Electrodermal activity and social network as predictors of outcome of episodes in schizophrenia.
Hultman CM; Ohlund LS; Wieselgren IM; Ohman A; Ost LG
J Abnorm Psychol; 1996 Nov; 105(4):626-36. PubMed ID: 8952196
[TBL] [Abstract][Full Text] [Related]
15. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
Roth WT; Goodale J; Pfefferbaum A
Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890
[TBL] [Abstract][Full Text] [Related]
16. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology.
Mackert A; Flechtner KM; Woyth C; Frick K
Schizophr Res; 1991; 4(1):41-7. PubMed ID: 1672606
[TBL] [Abstract][Full Text] [Related]
17. Prazosin, a specific alpha 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients.
Hommer DW; Zahn TP; Pickar D; van Kammen DP
Psychiatry Res; 1984 Mar; 11(3):193-204. PubMed ID: 6145176
[TBL] [Abstract][Full Text] [Related]
18. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
Schooler NR
Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
[TBL] [Abstract][Full Text] [Related]
20. Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen.
Weiden P; Rapkin B; Zygmunt A; Mott T; Goldman D; Frances A
Psychiatr Serv; 1995 Oct; 46(10):1049-54. PubMed ID: 8829787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
